Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial.
J. Infect. Dis., Dec;204(12):1918-26 (2011)
Immunogenicity and cross-reactivity of a representative ancestral sequence in hepatitis C virus infection.
J. Immunol., May;188(10):5177-88 (2012)
Analysis of HIV diversity using a high-resolution melting assay.
AIDS Res. Hum. Retroviruses., Aug;26(8):913-8 (2010)
Molecular epidemiology of HIV type 1 in Singapore and identification of novel CRF01_AE/B recombinant forms.
AIDS Res. Hum. Retroviruses., Oct;27(10):1135-7 (2011)
A 61 year-old female with a prior history of tuberculosis presenting with hemoptysis.
Clin. Infect. Dis., Apr;52(7):910, 957-9 (2011)
Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection.
J. Virol., May;84(10):5067-77 (2010)
Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus.
J. Virol., Jul;84(14):7018-28 (2010)
Evolution of the HIV-1 nef gene in HLA-B*57 positive elite suppressors.
Retrovirology., 7:94 (2010)
Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiretroviral
J. Virol., Oct;83(19):9731-42 (2009)
Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection.
Gastroenterology., Jan;138(1):315-24 (2010)
Genetic divergence of hepatitis C virus: the role of HIV-related immunosuppression.
J. Acquir. Immune Defic. Syndr., Oct;49(2):136-41 (2008)
HIV-1 evolution following transmission to an HLA-B*5801-positive patient.
J. Infect. Dis., Dec;200(12):1820-4 (2009)
Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C.
Hepatology., Jul;42(1):104-12 (2005)
Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy.
J. Virol., May;80(10):4758-70 (2006)
Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells.
J. Virol., Jul;80(13):6441-57 (2006)
A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts.
J. Virol. Methods., Sep;136(1-2):238-47 (2006)
Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution.
J. Virol., Jun;81(12):6513-22 (2007)
Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy.
AIDS Res. Hum. Retroviruses., Mar;23(3):381-90 (2007)
Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.
J. Infect. Dis., May;195(10):1402-10 (2007)
CD4+ T cell depletion in an untreated HIV type 1-infected human leukocyte antigen-B*5801-positive patient with an undetectable viral load.
Clin. Infect. Dis., Apr;46(8):e78-82 (2008)